New X-Ray Crystallography Study Confirms Structure of Empty Cowpea mosaic virus Particles
|
By LabMedica International staff writers Posted on 10 Apr 2016 |

Image: A study shows that a hollowed-out version of Cowpea mosaic virus could be useful in human therapies (Photo courtesy of the Scripps Research Institute).
An X-ray crystallography study confirmed that empty Cowpea mosaic virus (CPMV) particles (eVLPs) were structurally similar to the intact virus and showed that they could be used for drug transport and other biomedical applications.
CPMV is a plant virus of the Comovirus group. Its genome consists of two molecules of positive-sense RNA, which are separately encapsulated. The virus particles are 28 nanometers in diameter and contain 60 copies each of a Large (L) and Small (S) coat protein. The structure is well characterized to atomic resolution, and the viral particles are thermostable. CPMV displays a number of features that can be exploited for nanoscale biomaterial fabrication. Its genetic, biological, and physical properties are well characterized, and it can be isolated readily from plants. There are many stable mutants already prepared that allow specific modification of the capsid surface. It is possible to attach a number of different chemicals to the virus surface and to construct multilayer arrays of such nanoparticles on solid surfaces. This gives the natural or genetically engineered nanoparticles a range of properties which could be useful in nanotechnological applications such as biosensors, catalysis and nanoelectronic devices.
Empty CPMV particles (eVLPs) can be modified to entrap drugs or other molecules while the outside surface can be coated with peptides that direct the particles to a specific class of target cells.
Investigators at The Scripps Research Institute (La Jolla, CA, USA) reported in the March 24, 2016, online edition of the journal Structure that they had used X-ray crystallography at 2.3 angstrom resolution to determine the crystal structure of CPMV eVLPs and then compared it to previously reported cryo-electron microscopy (cryo-EM) reports of eVLPs and virion crystal structures.
The new study revealed that although the X-ray and cryo-EM structures of eVLPs were mostly similar, there existed significant differences at the C-terminus of the small (S) subunit. The intact C-terminus of the S subunit plays a critical role in enabling the efficient assembly of CPMV virions and eVLPs, but undergoes proteolysis after particle formation. In addition, the results of mass spectrometry-based proteomics analysis of coat protein subunits from CPMV eVLPs and virions showed that the C-termini of S subunits underwent proteolytic cleavages at multiple sites instead of a single cleavage site as previously observed.
"By studying the structure of the viral particles, we can get important information for transforming this plant virus into a useful therapeutic," said senior author Dr. Vijay Reddy, an associate professor at The Scripps Research Institute. "The eVLP is no longer a virus; it is just a protein capsule."
Related Links:
The Scripps Research Institute
CPMV is a plant virus of the Comovirus group. Its genome consists of two molecules of positive-sense RNA, which are separately encapsulated. The virus particles are 28 nanometers in diameter and contain 60 copies each of a Large (L) and Small (S) coat protein. The structure is well characterized to atomic resolution, and the viral particles are thermostable. CPMV displays a number of features that can be exploited for nanoscale biomaterial fabrication. Its genetic, biological, and physical properties are well characterized, and it can be isolated readily from plants. There are many stable mutants already prepared that allow specific modification of the capsid surface. It is possible to attach a number of different chemicals to the virus surface and to construct multilayer arrays of such nanoparticles on solid surfaces. This gives the natural or genetically engineered nanoparticles a range of properties which could be useful in nanotechnological applications such as biosensors, catalysis and nanoelectronic devices.
Empty CPMV particles (eVLPs) can be modified to entrap drugs or other molecules while the outside surface can be coated with peptides that direct the particles to a specific class of target cells.
Investigators at The Scripps Research Institute (La Jolla, CA, USA) reported in the March 24, 2016, online edition of the journal Structure that they had used X-ray crystallography at 2.3 angstrom resolution to determine the crystal structure of CPMV eVLPs and then compared it to previously reported cryo-electron microscopy (cryo-EM) reports of eVLPs and virion crystal structures.
The new study revealed that although the X-ray and cryo-EM structures of eVLPs were mostly similar, there existed significant differences at the C-terminus of the small (S) subunit. The intact C-terminus of the S subunit plays a critical role in enabling the efficient assembly of CPMV virions and eVLPs, but undergoes proteolysis after particle formation. In addition, the results of mass spectrometry-based proteomics analysis of coat protein subunits from CPMV eVLPs and virions showed that the C-termini of S subunits underwent proteolytic cleavages at multiple sites instead of a single cleavage site as previously observed.
"By studying the structure of the viral particles, we can get important information for transforming this plant virus into a useful therapeutic," said senior author Dr. Vijay Reddy, an associate professor at The Scripps Research Institute. "The eVLP is no longer a virus; it is just a protein capsule."
Related Links:
The Scripps Research Institute
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
VOCs Show Promise for Early Multi-Cancer Detection
Early cancer detection is critical to improving survival rates, but most current screening methods focus on individual cancer types and often involve invasive procedures. This makes it difficult to identify... Read more
Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
Kidney disease is typically diagnosed through blood or urine tests, often when patients present with symptoms such as blood in urine, shortness of breath, or weight loss. While these tests are common,... Read moreMolecular Diagnostics
view channel
Automated Test Distinguishes Dengue from Acute Fever-Causing Illnesses In 18 Minutes
Dengue fever remains the most common mosquito-borne viral infection worldwide, posing a major public health challenge as global cases continue to surge. In 2024 alone, more than 14.6 million infections... Read more
High-Sensitivity Troponin I Assay Aids in Diagnosis of Myocardial Infarction
Heart disease remains the leading cause of death for adults over 45 in the United States, accounting for nearly one in three deaths. In 2023 alone, 919,032 Americans died from cardiovascular disease —... Read more
Fast Low-Cost Alzheimer’s Tests Could Detect Disease in Early and Silent Stages
Early diagnosis remains one of the greatest challenges in combating Alzheimer’s disease, the most common cause of age-related dementia. With symptoms like memory loss and confusion typically appearing... Read more
Further Investigation of FISH-Negative Tests for Renal Cell Carcinoma Improves Diagnostic Accuracy
Accurate diagnosis of renal cell carcinoma (RCC) is critical to determining the right therapy, but standard diagnostic methods can sometimes miss important genetic alterations. Now, researchers have discovered... Read moreHematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read moreImmunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read moreMicrobiology
view channel
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3.8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after... Read morePathology
view channel
3D Genome Mapping Tool to Improve Diagnosis and Treatment of Genetic Diseases
Standard laboratory tests often fail to detect complex DNA rearrangements that underlie many genetic diseases. To bridge this diagnostic gap, researchers have developed a 3D chromosome mapping method that... Read more
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read moreTechnology
view channel
Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
Early diagnosis of psychiatric disorders such as depression, schizophrenia, and bipolar disorder remains one of medicine’s most pressing challenges. Current diagnostic methods rely heavily on clinical... Read more
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read moreIndustry
view channel
Co-Diagnostics Forms New Business Unit to Develop AI-Powered Diagnostics
Co-Diagnostics, Inc. (Salt Lake City, UT, USA) has formed a new artificial intelligence (AI) business unit to integrate the company's existing and planned AI applications into its Co-Dx Primer Ai platform.... Read more








